San Diego, California-based ResMed has received FDA 510(k) clearance for its small, portable continuous positive airway pressure (CPAP) device, the AirMini. The announcement was made during the JP ...

Poway, Calif.-based ResMed is recalling about 300,000 S8 flow generators, which are Continuous Positive Air Pressure devices, worldwide that are used to treat obstructive sleep apnea. S8 devices ...

Air Voel, a fast-growing Canadian provider of sleep therapy and respiratory care equipment, has announced the expansion ...

Sometimes one company's loss is another company's gain. In medtech, for example, Philips' recent recall on ventilators and sleep apnea devices could end up benefiting ResMed, a San Diego, CA-based ...

ResMed Inc.RMD recently announced positive results from a company-sponsored research, supporting the efficiency of bilevel devices. The results were presented at SLEEP, an annual joint meeting of the ...

After Philips issued a recall in mid-June of nearly two dozen models of its continuous and noncontinuous ventilators, ResMed has eagerly stepped up to fill in the market gap left by Philips’ absence.

California-based medical equipment manufacturer Resmed Inc. ( RMD) launched a continuous and automatic positive-airway pressure (PAP) device platform titled "AirSense 10." The AirSense 10 series PAP ...

(MENAFN- GetNews) Air Voel, a trusted name in sleep and respiratory wellness across Canada, proudly announces the expansion of its product lineup with the latest ResMed BiPAP and CPAP machines, ...

ResMed, a top maker of bedside sleep apnea machines, is tailoring its technology for the road. The San Diego medical device company said on Tuesday it’s launching the AirMini, a lightweight, ...

ResMed’s voluntary recall of some of its CPAP mask magnets has now been labeled as Class I by FDA. The agency announced the classification late last week. In November, ResMed began recalling some ...

By Byron Kaye SYDNEY, Feb 3 (Reuters) - Sleep-breathing device maker ResMed plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style weight ...